We are live on
!
Find out more
BCM
BBT Capital Management Portfolio holdings
AUM
$85.5M
1-Year Est. Return
11.09%
This Fund
S&P 500
This Quarter
Est. Return
+2.68%
1 Year Est. Return
-11.09%
3 Year Est. Return
+31.43%
5 Year Est. Return
+74.62%
10 Year Est. Return
–
AUM
$1.89B
AUM Growth
–
Cap. Flow
+$1.89B
Cap. Flow
% of AUM
99.99%
Top 10 Holdings %
Top 10 Hldgs %
24.59%
Holding
265
New
264
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$58.4M |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$36.2M |
| 3 |
EQT Corp
EQT
|
+$35.7M |
| 4 |
LyondellBasell Industries
LYB
|
+$33.4M |
| 5 |
NRG Energy
NRG
|
+$32.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 19.86% |
| 2 | Healthcare | 8.3% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Communication Services | 5.31% |
| 5 | Materials | 5.25% |
Similar funds
EBIM
ACP
BOE
FCA
TC
OFM
SCM
NC
BBT Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for BBT Capital Management, which disclosed 265 positions worth $1.89B. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Pfizer: 2,115,111 shares worth $56.2M.
By sector, the portfolio is most concentrated in Energy at 20% of assets, followed by Healthcare and Consumer Discretionary.
- BBT Capital Management's largest Q2 2013 buy was Pfizer: 2,115,111 shares worth $56.2M.
- BBT Capital Management's ten largest holdings make up 25% of its $1.89B portfolio in Q2 2013.
- BBT Capital Management disclosed 265 positions in Q2 2013, its first 13F filing on record.
Based on BBT Capital Management's 13F filing for Q2 2013, filed 7 Aug 2013.